Use of Imaging Modalities in Real Life: Impact on Visual Acuity Outcomes of Ranibizumab Treatment for Neovascular Age-Related Macular Degeneration in Germany.

ABSTRACT:

Background

To date, there are limited prospective real-world data on the impact of optical coherence tomography (OCT) diagnostics on treatment outcomes in neovascular age-related macular degeneration (nAMD). Therefore, the prospective, noninterventional OCEAN study (NCT02194803) evaluated the use of OCT imaging and its impact on functional outcomes in Germany.

Methods

The use of OCT imaging for treatment decisions was documented in nAMD patients receiving intravitreal ranibizumab injections at 347 study centres. Best-corrected visual acuity (BCVA) testing and treatment were performed according to routine clinical practice and documented over 24 months.

Results

The majority of the 3,631 nAMD patients (59.6%) received a combination of OCT and fluorescein angiography ima

SUBMITTER: Wachtlin J 

PROVIDER: S-EPMC7382751 | biostudies-literature | 2020

REPOSITORIES: biostudies-literature